In AD, KCNJ11 expression trended toward a decrease (β = –0.2150, P < 7.29 × 10–2), while ABCC8 was significantly reduced in AD brains (β = –0.2669, P < 3.7 × 10–2, respectively). The gene discussed is KCNJ11; the disease is Alzheimer disease.